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Resting naive CD8+ T cells have an astounding capacity to react to pathogens by massive expansion and
differentiation into cytotoxic effector cells that migrate to all corners of the body to clear the infection. The
initial interactionwith antigen-presenting cells in the central lymphoid organs drives an orchestrated program
of differentiation aimed at producing sufficient numbers of effectors to get the job done without resulting
in clonal exhaustion. Interactions with antigen-presenting cells and other immune cells continue at the site
of infection to regulate further on-site expansion and differentiation, all with the goal of protecting the host
with minimal bystander tissue damage. Here we review recent advances in CD8+ T cell recognition of antigen
in lymphoid as well as in nonlymphoid tissues in the periphery, and how CD8+ T cell expansion and differen-
tiation are controlled in these contexts.Introduction to Cytotoxic T Cells
Much of the early work that would eventually lead to the recog-
nition of antigen-specific cell-mediated lysis of target cells relied
on allogeneic, MHC-disparate tissue and tumor transplantation
models and allogeneic mixed lymphocyte cultures. In many of
these systems, a subset of thymus-derived T lymphocytes with
clonally distributed receptors was shown to be responsible for
in vitro cell-mediated lysis of target cells (Cantor and Boyse,
1975; Cerottini et al., 1970; Golstein et al., 1972). However, it
was work in a syngeneic system with lymphocytic choriomenin-
gitis virus (LCMV)-infectedmice that revealed the dual specificity
of specific T lymphocytes for viral antigen plus self-MHC that ex-
plained the involvement of MHC class I molecules with CD8+
T cell recognition of antigen and introduced the notion of ‘‘altered
self’’ (Zinkernagel and Doherty, 1974). Just how readily viruses
and other infections stimulate potent cytotoxic T lymphocyte
(CTL) responses is illustrated by human cases of acute infectious
mononucleosis or ‘‘kissing disease’’ caused by exposure to the
Epstein-Barr gamma herpes virus (EBV). The disease is charac-
terized by swollen lymph nodes and a remarkable rise in the
number of peripheral blood monocytes. In fact the bulk of the
monocytosis turns out to be a lymphocytosis consisting mostly
of activated CD8+ CTL with specificity for EBV peptides (Callan
et al., 1996). The response to EBV provides a remarkable ex-
ample of the magnitude of the proliferative burst of clones of
antigen-specific CD8+ lymphocytes in response to an infectious
agent. Similarly, it had been realized for many years that infection
of mice with LCMV led to an inversion of the CD4:CD8 ratio
because of a dramatic increase in CD8+ T cell numbers but it
was not until tetramer staining or the adoptive transfer of small
numbers of TCR transgenic CD8+ T cells was employed that it
was realized that the bulk of the CD8+ expansion was due to
antigen-driven proliferation (Butz and Bevan, 1998; Murali-
Krishna et al., 1998). During many infections, all T lymphocytes
regardless of specificity may undergo cytokine-driven pheno-
typic changes—so-called bystander activation—but only those
T cells that recognize pathogen-encoded antigen go through
multiple rounds of replication to generate enormous numbers
of CTL effector progeny that are the foot soldiers of the adaptive
immune response.Recruiting: Initial CD8+ T Cell Activation
During an infection, naive CD8+ T cells are primed by antigen-
presenting cells (APCs) in secondary lymphoid organs such as
lymph nodes (LN) and spleen. How are the CD8+ T cells activated
by the APCs? Seeing is believing. The application of multi-
photon-based intravital microscopy (IVM) has greatly advanced
our knowledge about immune response initiation. Previous work
had shown that in the absence of antigen, naive T cells in the LNs
engage in what appears to be a random walk in the T cell area,
which is actually their wandering on the fibroblastic reticular
network (Baje´noff et al., 2006). Subsequent to injection of
peptide-loaded dendritic cells (DCs), T cells scan the HEV-asso-
ciated DC forming antigen-specific contacts with the DCs,
leading to T cell activation (Bousso and Robey, 2003; Mempel
et al., 2004; Miller et al., 2003). However, because injected
peptide-pulsed DCs supply the antigenic stimulus in these
experiments, where and when APC and naive T cells interact
during an infection remained undefined. More recent research
has revisited this issue of CD8+ T cell recruitment in infectious
settings (Chtanova et al., 2009; Hickman et al., 2008; John
et al., 2009). Two groups using virus or parasite infection models
have shown that naive CD8+ T cells first contact the antigen-
bearing DCs in the subcapsular sinus region or the interfollicular
region of the draining LN (Hickman et al., 2008; John et al., 2009).
This peripheral location in the LN is in sharp contrast to the
central HEV region after peptide-pulsed DC immunization. In
naive mice, CD8+ T cells mainly reside in the T cell zones while
the DCs form an extensive network throughout the T cell zone,
B cell follicle, and some areas of the subcapsular sinus (Lindquist
et al., 2004). Shortly after infection, at the same time that the
infectious agents can be detected in the LNs, the CD8+ T cells
and DCs are quickly enriched in the peripheral regions of the no-
des (Hickman et al., 2008; John et al., 2009). Particulate antigen
and pathogens arrive via the lymphatics at the subcapsular sinus
of the draining LN. The first and major cell population infected by
pathogen is CD169+ macrophages lining the subcapsular sinus.
However, instead of these antigen-rich macrophages, naive
CD8+ T cells favor the DC population to deliver the first kiss to
start their differentiation to effector cells. During vaccinia virus
(VV) or vesicular stomatitis virus (VSV) infection, naive CD8+Immunity 35, August 26, 2011 ª2011 Elsevier Inc. 161
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In contrast, during Toxoplasma gondii infection, the relocation is
cognate antigen independent. Indeed, T. gondii infection
induces rapid remodeling of the lymph node architecture and
decreases the expression of chemokine CCL21 (John et al.,
2009), similar to the changes after LCMV infection (Mueller
et al., 2007). Distinct features of the VV, VSV, or T. gondii infec-
tion may contribute to the different mechanisms underlying
CD8+ T cell relocation. Upon T. gondii rechallenge, memory
CD8+ T cells migrate to the region close to the LN subcapsular
sinus to form contact with the APCs in an antigen-specific
fashion (Chtanova et al., 2009). Based on these observations,
we can conclude that shortly after a peripheral infection in
response to the gradient of cognate antigen and/or the dramatic
changes of the lymph node structure and chemokine levels,
naive CD8+ T cells quickly migrate toward the peripheral regions
of the T cell zone close to the subcapsular sinus region and the
infected macrophage population. Meanwhile, DCs also relocate
to the same area and acquire antigens from the infected cells
through direct infection or cross-presentation. At this peripheral
site of the LNs, initial antigen-specific contacts between the
CD8+ T cells and DCs are formed that lead to CD8+ T cell activa-
tion and expansion. Because the subcapsular region is close to
the antigen-rich region early during infection, it may be a more
efficient strategy to initiate an immune response in such a
specialized area of the lymph nodes.
How is the migration of DCs regulated during the initiation of
an immune response? Recently, the chemokine-chemokine
receptor pair XCL1-XCR1has emerged as a potentially important
contributor (Dorner et al., 2009). Expression of XCR1 is highly
restricted to the CD8a+ population of lymphoid tissue-resident
DCs. The ligand XCL1 is produced by activated CD8+ T cells. In
response to TCR stimulation, with kinetics of induction almost
identical to that of the early activation markers CD69 and CD25
(Dorner et al., 2009), the XCL1-XCR1 interaction plays an early
role during an immune response. Indeed, with XCL1-deficient
mice and anti-DEC205-mediated delivery of foreign antigen,
XCL1 is required for maximal priming and expansion of CD8+
T cells (Dorner et al., 2009). In addition, chemokines such as
CCL3, CCL4, and CCL17 produced by DCs have been shown
to attract cognate CCR5+ or CCR4+ naive CD8+ T cells during
priming (Castellino et al., 2006; Semmling et al., 2010). Therefore,
a feed forward loop between the CD8+ T cells and the DCs may
be established by these chemokine-chemokine receptor interac-
tions to maximize the recruitment of both antigen-specific naive
CD8+ T cells and DCs during priming. However, the role of these
chemokines during the initiation phase of a CTL response to
various infectious agents awaits further investigation.
At the peak of the primary response to pathogen, the popula-
tion of antigen-induced CD8+ effector T cells is phenotypically
and functionally heterogeneous. So-called short-lived effector
cells (SLEC) form the bulk of the population but will mostly die
off when infection is cleared, whereas memory precursor
effector cells (MPEC) that may have received less stimulation
survive and contribute preferentially to the memory population
(Mescher et al., 2006; Parish and Kaech, 2009). Elegant experi-
ments involving single-cell transfer and CD8+ T cell barcoding
demonstrate that a single naive CD8+ T cell can differentiate
into a diverse population of effector and memory cells (Gerlach162 Immunity 35, August 26, 2011 ª2011 Elsevier Inc.et al., 2010; Stemberger et al., 2007). In apparent contrast to
this notion of functional diversity arising from a single CD8+
T cell is the suggestion that CD8+ T cell fate is fixed to some
degree even before the first cell division. Use of a bicistronic
reporter mouse strain Ifng-YFP to visualize activation of the
gene encoding interferon (IFN)-g reveals that the YFP signal is
turned on within 24 hr of DC-peptide immunization (Beuneu
et al., 2010). Importantly, even before the first cell division,
a high degree of variation in the amount of YFP signal is observed
in the responding T cells. Interestingly, isolated single CD8+
T cells maintain their high versus low YFP signal intensity even
after a few rounds of cell division in vitro, i.e., the YFP signal
intensity is maintained stably throughout expansion. Higher
YFP signal intensity correlates with higher TNF-a and IL-2 pro-
duction (Beuneu et al., 2010). The variation of Ifng gene induction
reported by the YFP signal is controlled by the MHC-peptide
epitope density on the DC. Whether this early heterogeneity
contributes to the different effector and memory CD8+ T cell
differentiation in the long term is not resolved at present.
Because we know that a single CD8+ cell can give rise to heter-
ogenous progeny, i.e., SLEC and MPEC, then later encounters
with DCs as well as other extrinsic factors must be able tomodu-
late the differentiation. During bacterial, parasitic, or viral infec-
tion, factors such as inflammatory signals, costimulation, and
encounters with different APCs add another layer of complexity
during CD8+ effector T cell differentiation.
Other work suggests that CD8+ T cell clonal heterogeneitymay
be imposed at the first cell division. First division CD8+ T cells
segregate their protein degradation machinery in an asymmetric
manner, resulting in different amounts of the critical transcrip-
tional factor T-bet distributed to the two daughter cells (Chang
et al., 2011). Notably, even 2-fold differences in T-bet expression
can affect CD8+ T cell effector differentiationwith higher amounts
promoting SLEC differentiation (Joshi et al., 2007). The CD8hi
daughter cell (considered to be proximal to the APC) contains
fewer proteasomes and more T-bet whereas the CD8lo daughter
cell (distal) has more proteasomes and less T-bet. Genetic
models of Itk deficiency and SLP-76 mutation that fail to phos-
phorylate T-bet do not show asymmetric distribution of T-bet.
However, even though SLP-76 mutant CD8+ T cells cannot effi-
ciently degrade T-bet during the first cell division, SLP-76mutant
CD8+ T cells still develop into MPEC andmemory cells efficiently
after LCMV infection (Smith-Garvin et al., 2010). This latter finding
is inconsistent with the notion that the asymmetric distribution of
T-bet at the first division controls cell fate. Although asymmetric
cell division may play a fundamental role in development, asym-
metric distribution of the protein degradation machinery during
mitosis is an evolutionarily conserved strategy without any fate-
determining consequence. Even HeLa cells dividing in vitro
show asymmetric segregation of the protein-degradation ma-
chinery (Fuentealba et al., 2008). Proteasomes and proteins tar-
geted for degradation are concentrated in the pericentrosomal
region. During mitosis, whereas the centrioles and associated
centrosomal MTOC (microtubule organizing center) are divided
equally, the pericentrosomal materials remain largely in one
daughter cell. Whether asymmetric first cell division during the
CD8+ immune response is just another example of this conserved
phenomenon or has specific functional consequences for effec-
tor versus memory cell differentiation awaits discrimination.
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sentation efficiently recruit naive antigen-specific T cells into
an immune response. During rapid cell division, daughter cells
become heterogeneous by as yet undefined signals to provide
both short-lived effectors as well as memory precursors.
Preparing and Expanding the Troops
Calculations from data such as in Badovinac et al. (2007) imply
that a naive CD8+ T cell may go through as many as 19 cell divi-
sions in the week after pathogen stimulation, representing a
potential 500,000-fold expansion! The rate of maximal CD8+
cell division is usually quoted as 4–6 hr though one paper esti-
mates a 2 hr cycle (Yoon et al., 2010). Upon antigen priming,
resting naive T cells must undergo dramatic changes in metabo-
lism, such as enhanced uptake of glucose, amino acids, and iron
(Michalek and Rathmell, 2010). Another critical change is the
metabolic switch from oxidative phosphorylation to aerobic gly-
colysis, presumably to meet the sudden demand for the building
blocks of nucleic acids, lipids, and protein to make new cells
(Michalek and Rathmell, 2010; Vander Heiden et al., 2009).
How is this striking switch from rest to rapid expansion re-
gulated in T cells? Recently, it has been demonstrated that in
addition to costimulatory signals, such as CD28-induced
PI-3K-Akt-mTOR signaling (Michalek and Rathmell, 2010),
TCR-ERK signaling is required for enhanced glycolysis and
glucose plus glutamine uptake (Carr et al., 2010; Marko et al.,
2010). Surprisingly, phosphoinositide-dependent kinase 1
(PDK1), but not Akt, is required for CD8+ T cell proliferation and
glucose metabolism in vitro (Macintyre et al., 2011). Consistent
with these data, PTEN deficiency or constitutively active Akt
does not improve antigen-specific CD8+ T cell expansion during
LCMV infection (Hand et al., 2010). Indeed, constitutive Akt
signaling induces more dramatic contraction and defective
memory cell formation. However, PDK1 is not involved in amino
acid uptake in activated CD8+ T cells (Macintyre et al., 2011).
Therefore, other pathwaysmay exist to regulate different aspects
of activated CD8+ T cell metabolism. Indeed, TCR engagement
alone leads to the activation of multiple molecular pathways,
including MAPK and mTOR to activate ribosomal protein S6
and the protein translation machinery (Salmond et al., 2009).
mTOR is a conserved environmental sensor that controls cell
growth, proliferation, and metabolism (Powell and Delgoffe,
2010). According to dogma, TCR plus CD28 and cytokine recep-
tor stimulation activates the PI-3K-PDK1-Akt pathway. In turn,
activated Akt induces mTOR activity, which leads to the activa-
tion of multiple downstream targets, including 4E-BP1 and
S6K1 (Powell and Delgoffe, 2010). However, because Akt activity
is not required for IL-2-induced activatedCD8+ T cell proliferation
andmetabolism in vitro (Macintyre et al., 2011), this classic path-
way may need to be modified. Nevertheless, the metabolic
changes are critical for effector CD8+ T cell differentiation.
To achieve maximal expansion, CD8+ T cells need to integrate
multiple signals, including the TCR, costimulatory signals, and
inflammatory cytokines, such as IL-12 and type I IFN (Mescher
et al., 2006; Parish and Kaech, 2009). Many members of the
tumor necrosis factor receptor (TNFR) family such as 4-1BB,
CD27, and OX-40 deliver important costimulatory signals to
CD8+ T cells (Watts, 2005). Another TNFR family member, gluco-
corticoid-induced TNFR-related protein (GITR), delivers a pro-survival signal to effector CD8+ T cells to promote CD8+ T cell
expansion and protect mice from severe influenza virus infection
(Snell et al., 2010). In addition, MyD88, a well-studied adaptor
molecule in innate immunity that is essential for most TLR and
IL-1 and IL-18 signaling, has an intrinsic role in CD8+ T cells.
With adoptive transfer of T cells, mixed bone marrow chimeric
mice, or T cell-specific deletion of MyD88, several groups have
demonstrated an intrinsic role for MyD88 in effector T cell expan-
sion and survival subsequent to a variety of infectious agents
(Bartholdy et al., 2009; Quigley et al., 2009; Rahman et al.,
2008; Zhao et al., 2009). TLR2 signaling in CD8+ T cells induces
mammalian target of rapamycin (mTOR) activation, which in turn
promotes T-bet synthesis and cytolytic effector gene transcrip-
tion in vitro (Geng et al., 2010). However, inconsistent results
were obtained regarding the in vivo role of TLR2 during infections
(Quigley et al., 2009; Zhao et al., 2009). Therefore, a resolution of
which upstream signals activate MyD88 in CD8+ T cells awaits
further studies. Interestingly, although MyD88 is critical for
CD8+ T cell primary expansion, it does not appear to be required
for the CD8+ memory T cell recall response to LCMV infection
(Rahman et al., 2011).
From these studies it is clear that the dramatic rate of expan-
sion of CD8+ T cells responding to pathogen-encoded antigen
depends on signals from multiple receptors that impinge upon
cell division and cell survival.
Weaponry: Terminal Effector Differentiation
Proinflammatory cytokines, such as IL-12, play a key role in
terminal differentiation of CD8+ effector T cells (Curtsinger
et al., 2003; Pearce and Shen, 2007). Mechanistically, IL-12 pro-
motes effector CD8+ T cell differentiation through the induction
of T-bet (Joshi et al., 2007; Takemoto et al., 2006) via an
mTOR-dependent pathway (Rao et al., 2010).
IL-2 was originally defined as a T cell growth factor in vitro. It is
predominately produced by activated CD4+ T cells and at lower
amounts by activated CD8+ T cells (Malek and Castro, 2010).
The in vivo role of IL-2 signaling in CD8+ T cells during infections
has been elucidated with CD25-deficient (Il2ra/) and wild-type
(WT) mixed bone marrow chimeric mice. Clonal expansion is
only slightly decreased in cells lacking CD25 but they show
phenotypic and functional alterations (Bachmann et al., 2007;
Obar et al., 2010; Williams et al., 2006). Compared to control
cells, the induced and expanded Il2ra/ effector CD8+ T cells
exhibit a trend toward a more MPEC or central memory (Tcm)
cell phenotype during primary responses, including increased
CD62L and CD127 and decreased KLRG1 expression. Recent
papers have established an important function for IL-2 in CD8+
effector T cell terminal differentiation. Consistent with the pre-
vious results with a similar in vitro culture system (Carrio et al.,
2004), Pipkin et al. (2010) show that activated CD8+ T cells
cultured in a high concentration of IL-2 gradually acquire supe-
rior effector functions compared with cells cultured in low con-
centrations of IL-2. After adoptive transfer in vivo, CD8+ T cells
from high IL-2 cultures fail to maintain their number over the
long term and are delayed in upregulating CD62L expression.
Il2ra/ CD8+ effector T cells are defective in ex vivo killing,
correlated with the decreased expression of granzymeB and
perforin (Pipkin et al., 2010). Another study reports that whereas
CD25 expression is uniformly high on antigen-specific CD8+Immunity 35, August 26, 2011 ª2011 Elsevier Inc. 163
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Figure 1. IL-2- and Blimp-1-Dependent Effector CD8+ T Cell
Differentiation
After antigen priming, activated CD8+ T cells receive signals from multiple
cytokines such as IL-2, IL-21, Il-12, and Il-27. IL-2 signaling induces Blimp-1
expression which cooperates with other transcription factors to promote CD8+
(CTL) T cell effector differentiation, migration to the peripheral sites during
acute infection, and exhaustion during chronic infection while inhibiting MPEC
and Tcm cell differentiation.
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pattern is evident by day 3.5–5 postinfection (Kalia et al., 2010).
After isolation at this stage and transfer into infection-matched
recipient mice, CD25hi cells go on to express higher amounts
of KLRG1 and granzymeB and lower amounts of CD62L and
IL-2 compared with transferred CD25lo cells. CD25hi cells are
defective in their long-term homeostasis and their recall
response. Detailed analysis reveals that the KLRG1hiCD127lo
SLEC population drops to less than 10% of control cells in the
absence of CD25 during the contraction phase (Mitchell et al.,
2010). Taken together, these results demonstrate that IL-2 sig-
naling, delivered early after infection, promotes SLEC differenti-
ation. In the absence or decreased amount of IL-2 signaling,
CD8+ T cells exhibit defective effector function and preferentially
become CD62Lhi memory cells. This conclusion has been further
confirmed with gc-deficient CD8
+ T cells (Decaluwe et al., 2010).
IL-2 is therefore better viewed as a differentiation factor than as
a growth factor during the in vivo response to pathogens.
What are the downstream targets of IL-2 signaling that
promote effector CD8+ T cell development? IL-2 signaling acti-
vates multiple molecular pathways, including STAT5, PI-3K,
and MAPK (Malek and Castro, 2010). Therefore, distinct mole-
cules may contribute to different aspects of effector CD8+
T cell differentiation.
IL-2 signals activate the transcriptional repressor Blimp-1
(encoded by the Prdm1 gene) and Blimp-1 inhibits IL-2 produc-
tion (Malek and Castro, 2010). Three groups have studied the
requirement for Blimp-1 during CD8+ effector T cell development
(Kallies et al., 2009; Rutishauser et al., 2009; Shin et al., 2009).
The expression of Blimp-1 in CD8+ T cells is largely confined to
the KLRG1hiCD127lo SLEC population during acute infections,
decreasing as memory cells are formed (Kallies et al., 2009;
Rutishauser et al., 2009). During chronic viral infection, Blimp-1
is expressed at a much higher level than during acute infection
(Shin et al., 2009). In the absence of Blimp-1, clonal expansion
of CD8+ T cells is apparently normal during primary infection
with LCMV whereas the contraction is delayed (Rutishauser
et al., 2009). Interestingly, during influenza virus respiratory
infection, Prdm1/ effector CD8+ T cells are defective in accu-
mulation in the lung presumably because of slightly decreased
CCR5 expression (Kallies et al., 2009). However, a migratory
defect is not obvious during LCMV infection (Rutishauser et al.,
2009). One striking phenotype of Prdm1-deficient CD8+ T cells
is that they exhibit severe defects in effector functions and
SLEC differentiation. Instead, Prdm1/ CD8+ T cells more
readily upregulate MPEC markers. For example, Prdm1/
CD8+ T cells express lower amounts of granzymeB, perforin,
and KLRG1 but have higher amounts of CD127, CCR7, CD62L,
CD27, and IL-2. During chronic infection, Blimp-1 deficiency in
CD8+ T cells leads to decreased expression of multiple in-
hibitory receptors associated with CD8+ T cell exhaustion,
such as PD-1, LAG-3, CD160, and 2B4 (Shin et al., 2009). Inter-
estingly, Blimp-1 haploinsufficiency in antigen-specific CD8+
T cells leads to enhanced virus clearance because of balancing
decreased expression of inhibitory receptors with maintenance
of sufficient effector function (Shin et al., 2009). Because clonally
exhausted CD8+ T cells may be considered an extreme state of
effector cells, all these results demonstrate that Blimp-1 is an
important regulator of SLEC differentiation. Several transcrip-164 Immunity 35, August 26, 2011 ª2011 Elsevier Inc.tional regulators are differentially expressed between Prdm1/
and WT CD8+ effector cells. Those factors promoting CD8+
memory cell differentiation such as Tcf-1, Bcl6, and Eomes are
inhibited by Blimp-1 whereas those promoting CD8+ effector
cell differentiation such as Tbx21 and Id2 are enhanced by
Blimp-1 (Kallies et al., 2009; Rutishauser et al., 2009). Among
these transcriptional regulators, Bcl-6 is another transcription
repressor that functions as a reciprocal antagonist of Blimp-1
in B cells, CD4+ T cells, and probably also in CD8+ T cells (Crotty
et al., 2010). Blimp-1 may be a critical factor pushing SLEC
differentiation downstream of IL-2 signals (Figure 1).
There are several differences between Il2ra/ and Prdm1/
CD8+ T cells. Il2ra/ antigen-specific CD8+ T cells disappear
rapidly during chronic LCMV infection whereas Prdm1/ cells
are maintained at a normal to slightly higher numbers than
control CD8+ T cells (Bachmann et al., 2007; Shin et al., 2009).
These differences are due to two main reasons. First, IL-2 sig-
naling modulates other intracellular pathways in CD8+ T cells.
For example, IL-2 inhibits the activity of Foxo through a PDK1-
Akt-dependent mechanism (Macintyre et al., 2011). Foxo
induces another transcription factor, KLF2, that activates several
key molecules related to effector T cell migration including
CD62L, S1P1, and CCR7 (Takada et al., 2011). Second, in addi-
tion to IL-2, other cytokines, such as IL-12, IL-27, and IL-21,
might induce Blimp-1 expression in activated CD8+ T cells
(Gong and Malek, 2007; Kwon et al., 2009; Sun et al., 2011).
Like Blimp-1, IL-21 signaling plays an important role in CD8+
T cells during chronic viral infection (Elsaesser et al., 2009;
Fro¨hlich et al., 2009; Yi et al., 2009).
Besides the differences between IL-2 signaling-induced
and Blimp-1-controlled molecular pathways, Blimp-1 may not
lie in the center of effector CD8+ T cell differentiation program.
The transcriptional regulators that are differentially expressed
between Prdm1/ and WT cells may not lie downstream of
Blimp-1. A large group of genes differentially expressed between
Prdm1/ andWT cells do not contain Blimp-1 binding sites and
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In addition, other factors may affect CD8+ effector cell fate
decision. Runx3, Notch2, and the canonical Wnt pathway
effector, Tcf-1, are all involved in CD8+ effector T cell differen-
tiation (Cruz-Guilloty et al., 2009; Jeannet et al., 2010; Maekawa
et al., 2008; Zhou et al., 2010). Interestingly, the expression of
Tcf-1 is substantially perturbed in the absence of Blimp-1,
PDK1, or active Akt (Macintyre et al., 2011; Rutishauser et al.,
2009). In summary, we have just begun to elucidate the molec-
ular pathways controlling CD8+ effector T cell differentiation.
The interactions and relationships between different signaling
pathways and transcriptional regulators will hold the key toward
better understanding of the molecular control of CD8+ effector
T cell development.
Getting There: Migration of Effector CTL
Shortly after recognition of antigen on DCs in the central lym-
phoid organs, activated T cells upregulate the inflammatory
cytokine receptor, CXCR3, allowing them to enter peripheral
tissues (Groom and Luster, 2011). CD4+ T cell help in activating
the APC is required for the generation of the CD8+ primary
response to noninflammatory antigens and certain viral infec-
tions such as herpes simplex virus (HSV), whereas the primary
CD8+ response to influenza, Listeria, and LCMV infection is
CD4+ T cell independent (Bevan, 2004). An additional function
of CD4+ T cell help is apparent in peripheral infected tissues
where it is required for the enhanced recruitment of CTL into
the infected site (Nakanishi et al., 2009). After vaginal infection
with HSV-2, CD4+ effector T cells enter the infected vaginal
tissues earlier than CD8+ effector T cells. CD4+ cells secrete
IFN-g, presumably in response to seeing antigen at the site,
promoting the vaginal epithelium to secrete CXCL9 and
CXCL10, which guide the migration of CD8+ effector cells into
the infected tissues through a CXCR3-dependent mechanism
(Nakanishi et al., 2009). Other peripheral tissues such as lung
and intestine show no requirement for CD4+ help for the recruit-
ment of effector CD8+ T cells in this model but these sites do not
express viral antigen. Infected skin may be another site that
requires CD4+ T cell help to more efficiently attract effector
CD8+ T cells (Gebhardt and Carbone, 2009).
Even after leaving the central lymphoid organs and trafficking
via the blood to the peripheral site of infection, CD8+ effector CTL
continue to engage in antigen-specific interactions that (apart
from resulting in cytolysis of infected targets) drive further pro-
liferation and cytokine release. A combination of local CFSE
and BrdU administration reveals extensive continued prolifera-
tion of newly arrived CTL in the lung contributing substantially
to the overall magnitude of the response to influenza infection
(Bedoui and Gebhardt, 2011; McGill and Legge, 2009). The
greatest on-site proliferation coincides with the appearance in
the lung onmonocyte-derived inflammatory DCs. Another recent
study, also with sublethal influenza infection, demonstrates that
although infected lung epithelial cells can trigger CTL degranula-
tion and killing, inflammatory cytokine secretion requires antigen
presentation by CD11c+ hematopoietic cells expressing costi-
mulatory ligands (Hufford et al., 2011). Whether recruited mono-
cyte-derived inflammatory APCs present antigen by becoming
infected themselves or by cross-presentation or cross-dressing
is not known (Wakim and Bevan, 2011). Thus we see that evenafter migration from the central lymphoid organs where the
response initiates, CD8+ T cell interactions with helper T cells
and with specialized APCs continue at peripheral sites of
infection.
Discipline: Self-Control by CD8+ Effectors
In addition to killing infected cells and releasing cytokines such
as IFN-g at the peripheral site of infection, recent reports have
assigned another duty to effector CD8+ T cells, namely to serve
a regulatory role in preventing excessive tissue injury by secre-
tion of the immunosuppressive cytokine IL-10 (Palmer et al.,
2010; Sun et al., 2009; Trandem et al., 2011). Originally defined
as a Th2 cytokine, IL-10 is secreted by multiple cell types,
including B cells, NK cells, NKT cells, macrophages, DCs,mono-
cytes, and different effector CD4+ T cell subsets (Th1, Th2, Th17,
and Treg cells) (Saraiva and O’Garra, 2010). Fully differentiated
effector CD8+ T cells produce large amounts of IL-10 at local
infection sites in different viral infection models in the lung and
brain (Palmer et al., 2010; Sun et al., 2009; Trandem et al.,
2011). At the peak of the response, CD8+ T cells are the major
producers of IL-10 at these peripheral sites whereas in sec-
ondary lymphoid organs, CD4+ T cell-derived IL-10 dominates
(Palmer et al., 2010; Sun et al., 2009; Trandem et al., 2011).
During the later phase of the response when the infection has
been controlled, IL-10+CD8+ T cells rapidly disappear while
IL-10+ CD4+ cells persist, suggesting that different mechanisms
regulate IL-10 production in CD8+ versus CD4+ T cells. Com-
pared with their IL-10 colleagues at the site of infection, IL-
10+CD8+ T cells are superior killers and produce normal to higher
amounts of granzymeB, IFN-g, and TNF-a. Importantly, IL-10
produced by effector CD8+ T cells is critical to prevent immuno-
pathology during viral infection without affecting the kinetics of
viral clearance. It is important to note that the IL-10-producing
subset of CD8+ effector T cells does not represent a divergent
effector lineage; rather, it is a transient and reversible state of
CD8+ effector T cell differentiation to better balance clearance
of the infection with bystander tissue damage. Thus, after trans-
fer into infected hosts, both IL-10+ and IL-10 effector CD8+
T cells differentiate into a population with a similar percentage
of IL-10-producing cells in a coronavirus-induced encephalitis
model (Trandem et al., 2011).
What extracellular stimuli and intracellular signaling pathways
control IL-10 production in CD8+ T cells at peripheral sites of
acuteviral infection? InCD4+Tcells, IL-10production is regulated
by a variety of mechanisms. For instance, GATA3 and STAT6 are
required for IL-10 production in Th2 cells (Saraiva and O’Garra,
2010). IRF4 and Blimp-1 regulate IL-10 in a subset of Treg cells
(Cretney et al., 2011). IL-12-STAT4 and maybe c-maf control
IL-10 in Th1cells (Saraiva et al., 2009). c-maf andAhr (acryl hydro-
carbon receptor) are essential for IL-10 induction in Tr1 cells
(Apetoh et al., 2010). In addition, strong TCR stimulation and
ERK activation promote IL-10 production in Th1 cells (Saraiva
et al., 2009). For CD8+ T cells, during intranasal influenza virus
infection, IL-10 production requires the synergistic cooperation
between CD4+ T cell-derived IL-2 and innate (mainly neutrophil)
derived IL-27 (Sun et al., 2011). Blimp-1 expression in CD8+
T cells is essential for IL-10 production and the level of Blimp-1,
but not T-bet or c-maf, correlates with the degree of IL-10 induc-
tion (Sun et al., 2011). Considering the aforementioned function ofImmunity 35, August 26, 2011 ª2011 Elsevier Inc. 165
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Figure 2. Self-Control by Effector CD8+ T Cells
In infected peripheral tissues, some effector CD8+ (CTL) T cells receive addi-
tional local signals including antigen, CD4+ T cell-derived IL-2, and innate cell-
derived IL-27, and transiently acquire the ability to secrete IL-10 in a Blimp-1-
dependent manner. CTL-derived IL-10 is critical to control local inflammation
and tissue damage.
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suggest that IL-10 productionmay be a part of the full CD8+ T cell
effector differentiation program. Strong or continued TCR-MAPK
signaling may also promote IL-10 production because the
majority of IL-10+CD8+ T cells are CD69+ during coronavirus
infection, suggesting recent TCR stimulation (Trandem et al.,
2011). Consistent with this notion, potent TCR stimulation may
be a common signal to induce IL-10 in peripheral effector CD8+
T cells because IL-10 production drops quickly after virus clear-
ance in both influenza virus and coronavirus models (Sun et al.,
2009; Trandem et al., 2011). The requirement for Blimp-1, IL-2,
and IL-27 in IL-10 secretion has been confirmed in a well-
controlled in vitro culture system (Sun et al., 2011) and these
factors plus antigen stimulation may be the general requirements
for IL-10 production in effector CD8+ T cells (Figure 2).
A dynamic picture emerges from these important recent
discoveries. Upon acute infection, naive CD8+ T cells receive
cognate antigen stimulation and differentiate into effector T cells
in a highly regulated way including IL-2- and Blimp-1-dependent
mechanisms. After migrating to the sites of infection, to protect
the normal physiologic functions of these critical organs, such
as thebrain and the lung, someeffectorCD8+T cells receive addi-
tional local signals including antigen, IL-2, and IL-27 and tran-
siently acquire the ability to secrete IL-10 in a Blimp-1-dependent
manner. Future experiments will determine whether IL-10+CD8+
T cells arise at other sites of infection with other pathogens.
More than 400 differentially expressed genes are identified
between IL-10+ and IL-10CD8+ effector T cells in the corona-
virus model (Trandem et al., 2011), raising the possibility that
there are other functions associated with IL-10 production by
CD8+ effector T cells. Answers to these questions will broaden
and deepen our knowledge about the role of CD8+ T cells in pro-
tecting against immunopathology at sites of infection.
Concluding Remarks
After infection and MHC class I antigen processing and presen-
tation, antigen-specific CD8+ T cells receive multiple extracel-166 Immunity 35, August 26, 2011 ª2011 Elsevier Inc.lular signals to initiate rapid proliferation and a sophisticated
CTL differentiation program. A large number of signaling path-
ways cooperate to regulate CD8+ T cell proliferation, survival,
migration, metabolism, and acquisition of effector functions.
Even after effector T cells reach peripheral sites of infection,
interactions with other professional hematopoietic cells con-
tinue to guide the terminal differentiation of the cells. A better
understanding of the process of CD8+ effector T cell differentia-
tion is key to aid future vaccine design and to better manipulate
CD8+ effector function in order to maximize pathogen clearance
while minimizing any associated immunopathology.
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